GGrantIndex
Sort

39,280 grants matching leukemia

RNA Splicing Modulators for MDS/AML

$427,150
Timothy A Graubert · Washington University · P50 · FY2017 · CA

Targeting PLK1 in RAS mutant chronic myelomonocytic leukemia

$427,131
Mrinal Shiv Patnaik · Mayo Clinic Rochester · R01 · FY2023 · CA

Targeting PLK1 in RAS mutant chronic myelomonocytic leukemia

$427,131
Mrinal Shiv Patnaik · Mayo Clinic Rochester · R01 · FY2025 · CA

Molecular Pathogenesis of AF10-Rearranged Leukemias

$427,097
Aniruddha J. Deshpande · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2024 · CA

Hematopoietic Stem Cell Aging

$427,075
Danica Chen · University Of California Berkeley · R01 · FY2021 · DK

Hematopoietic Stem Cell Aging

$427,075
Danica Chen · University Of California Berkeley · R01 · FY2020 · DK

ROLE OF C/EBPalpha AND MYELOPOIESIS

$427,024
Daniel G Tenen · Beth Israel Deaconess Medical Center · R01 · FY2006 · HL

Project 1: Overcoming resistance of B cell leukemia to CD19 CAR T Cells.

$427,021
David Porter · University Of Pennsylvania · P01 · FY2019 · CA

BIOMARKERS OF BENZENE EXPOSURE AND GENOTOXICITY

$427,014
University Of California Berkeley · R01 · FY2001 · ES

Insights into Structure-Function Relationships of Matrix Metalloproteinase-1 from Computational and Experimental Studies

$427,001
Tatyana Karabencheva-Christova · Michigan Technological University · R15 · FY2023 · GM

The role of leukemia inhibitory factor in colorectal cancer

$426,972
Wenwei Hu · Rutgers Biomedical And Health Sciences · R01 · FY2025 · CA

Southern Oncology Network on Adverse Reactions (SONAR) - Focus on Tyrosine Kinase

$426,959
Charles Lee Bennett · University Of South Carolina At Columbia · R01 · FY2014 · CA

Unbiased identification of spliceosome vulnerabilities across cancer

$426,923
Nathan G. Salomonis · Cincinnati Childrens Hosp Med Ctr · R01 · FY2019 · CA

Intrinsic and Extrinsic Factors Contributing to Trisomy 21 Preleukemia

$426,919
Elvin Wagenblast · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · CA

Precision Targeting of Myeloid Src-family Kinases in Acute Myelogenous Leukemia

$426,919
Thomas Edward Smithgall · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · CA

Precision Targeting of Myeloid Src-family Kinases in Acute Myelogenous Leukemia

$426,919
Thomas Edward Smithgall · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · CA

Intrinsic and Extrinsic Factors Contributing to Trisomy 21 Preleukemia

$426,919
Elvin Wagenblast · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · CA

Pharmacokinetic / Pharmacodynamic Optimization of ADC Therapy for Acute Myeloid Leukemia

$426,903
Joseph P Balthasar · State University Of New York At Buffalo · R01 · FY2023 · CA

Mechanisms of inv(16) acute myeloid leukemia

$426,803
Lucio H. Castilla · Univ Of Massachusetts Med Sch Worcester · R01 · FY2021 · CA

Mechanisms of inv(16) acute myeloid leukemia

$426,803
Lucio H. Castilla · Univ Of Massachusetts Med Sch Worcester · R01 · FY2017 · CA

Mechanisms of inv(16) acute myeloid leukemia

$426,803
Lucio H. Castilla · Univ Of Massachusetts Med Sch Worcester · R01 · FY2020 · CA

Reducing racial/ethnic inequities in childhood cancer survivorship

$426,779
Joel E Milam · University Of Southern California · R01 · FY2014 · MD

Training Program in Molecular Hematology

$426,770
Oregon Health And Science University · T32 · FY2003 · HL

Regulation and Targets of the DNA Damage Checkpoint

$426,730
David P Toczyski · University Of California, San Francisco · R01 · FY2010 · GM

Project 1 BCL11A Protein in Hemoglobin Regulation, Stuart H. Orkin

$426,728
Stuart H Orkin · Boston Children'S Hospital · P01 · FY2017 · HL